October 2023
Department of Health in collaboration with M42 envision the Abu Dhabi Biobank
At the heart of our mission is a profound commitment to public health, guided by our ethos of fostering community well-being and expanding people’s healthcare options and opportunities.
We recognize that preserving vital human samples is crucial for advancing medical science and improving people’s health outcomes. Through our dedicated biobanking services, we ensure these invaluable resources are stored with the highest levels of integrity and care, making them accessible for future use, treatment, and research.
Department of Health in collaboration with M42 envision the Abu Dhabi Biobank
Validation of samples completed, and training programs initiated
Abu Dhabi Biobank launched formally at Abu Dhabi Global healthcare Week
Danat Al Emarat Hospital, Kanad Hospital and Corniche Hospital join forces to spread awareness about the program
Expectant families come forward and extend their support to cord blood banking initiative
Department of Health - Abu Dhabi is the regulative body of the Healthcare Sector in the Emirate of Abu Dhabi and ensures excellence in healthcare for the community by monitoring the health status of the population. DoH defines the strategy for the health system, monitors and analyses the health status of the population and performance of the system.
DoH and M42 have collaborated to launch a groundbreaking initiative and strategic priority, the Abu Dhabi Biobank, with its first offering being the region’s largest hybrid cord blood bank. Reinforcing the Emirate’s position as a leading destination for life sciences, the initiative aims to shorten waiting times for treatment, increase therapeutic access for patients, improve survival rates and reduce the economic burden on governments.
M42 is a first-of-its-kind, global tech-enabled health powerhouse committed to the sustainable future of health. The Abu Dhabi-headquartered company is transforming lives through innovative solutions that are solving the world’s most critical health and diagnostic challenges. By harnessing unique medical and data-centric technologies, including genomics and AI, M42 is delivering the highest level of personalized, precise, and preventative health solutions to impactfully disrupt the global health landscape.
M42 is committed to advancing health by delivering the highest level of personalized, precise, and preventative health solutions for all and believes that the Abu Dhabi Biobank will foster global innovation in therapy development, as it holds huge potential for regenerative medicine, aiding in rare disease treatment, genetic screening, early detection, and scientific research.